We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.33B
AUM Growth
+$519M
Cap. Flow
+$261M
Cap. Flow %
11.2%
Top 10 Hldgs %
31.18%
Holding
1,170
New
202
Increased
753
Reduced
172
Closed
43

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$13.4M
2
TSLA icon
Tesla
TSLA
+$13.2M
3
MSFT icon
Microsoft
MSFT
+$5.94M
4
AAPL icon
Apple
AAPL
+$5.64M
5
NVDA icon
NVIDIA
NVDA
+$5.32M

Sector Composition

Rank Sector Weight
1 Technology 39.75%
2 Healthcare 13.35%
3 Consumer Discretionary 11.99%
4 Communication Services 9.24%
5 Energy 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
176
Arrowhead Research
ARWR
$12.1B
$1.94M 0.08%
63,553
+9,636
+18% +$256K
SPGI icon
177
S&P Global
SPGI
$126B
$1.94M 0.08%
4,407
+714
+19% +$282K
SHW icon
178
Sherwin-Williams
SHW
$78.3B
$1.93M 0.08%
6,191
-35
-0.6% -$9.41K
BHVN icon
179
Biohaven
BHVN
$2.16B
$1.91M 0.08%
44,513
-13,001
-23% -$404K
BPMC
180
DELISTED
Blueprint Medicines
BPMC
$1.9M 0.08%
20,628
-8,035
-28% -$521K
SRE icon
181
Sempra
SRE
$60.8B
$1.9M 0.08%
25,444
-710
-3% -$50.8K
TCOM icon
182
Trip.com Group
TCOM
$27.5B
$1.9M 0.08%
52,657
+14,396
+38% +$491K
ELV icon
183
Elevance Health
ELV
$81.9B
$1.89M 0.08%
4,018
+367
+10% +$170K
FOLD
184
DELISTED
Amicus Therapeutics
FOLD
$1.88M 0.08%
132,406
+10,199
+8% +$116K
MDT icon
185
Medtronic
MDT
$107B
$1.88M 0.08%
22,764
+2,332
+11% +$178K
DVN icon
186
Devon Energy
DVN
$51.9B
$1.88M 0.08%
41,392
+2,492
+6% +$114K
BBIO icon
187
BridgeBio Pharma
BBIO
$16.5B
$1.87M 0.08%
46,347
-7,522
-14% -$226K
GE icon
188
GE Aerospace
GE
$367B
$1.86M 0.08%
18,288
+2,689
+17% +$249K
INCY icon
189
Incyte
INCY
$23.5B
$1.83M 0.08%
29,081
+3,361
+13% +$190K
ALKS icon
190
Alkermes
ALKS
$8.82B
$1.81M 0.08%
65,215
+11,045
+20% +$287K
NIO icon
191
NIO
NIO
$11.3B
$1.8M 0.08%
198,513
+54,500
+38% +$433K
EXEL icon
192
Exelixis
EXEL
$13.9B
$1.79M 0.08%
74,495
-194
-0.3% -$4.22K
WPM icon
193
Wheaton Precious Metals
WPM
$50.6B
$1.78M 0.08%
35,994
+1,996
+6% +$90.3K
GDDY icon
194
GoDaddy
GDDY
$12.3B
$1.77M 0.08%
16,682
-2,217
-12% -$198K
AKAM icon
195
Akamai
AKAM
$16.8B
$1.76M 0.08%
14,909
-188
-1% -$20.9K
IBN icon
196
ICICI Bank
IBN
$106B
$1.76M 0.08%
73,967
-1,546
-2% -$35.6K
VEEV icon
197
Veeva Systems
VEEV
$30.3B
$1.76M 0.08%
9,153
+1,125
+14% +$212K
RVMD icon
198
Revolution Medicines
RVMD
$40.2B
$1.75M 0.08%
61,107
+21,711
+55% +$522K
CVS icon
199
CVS Health
CVS
$137B
$1.73M 0.07%
21,969
+2,257
+11% +$161K
RTX icon
200
RTX Corp
RTX
$287B
$1.72M 0.07%
20,452
+3,805
+23% +$301K

Similar funds

Profund Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Profund Advisors held 1,170 positions worth $2.33B, up 29% from $1.81B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Profund Advisors deployed $261M of net new capital in Q4 2023, opening 202 new positions and adding to 753 existing holdings. Its largest new stake was Coca-Cola Europacific Partners: 35,352 shares worth $2.36M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was eBay, an estimated $1.3M trimmed.

  • Profund Advisors's largest Q4 2023 buy was Coca-Cola Europacific Partners: 35,352 shares worth $2.36M.
  • Profund Advisors added most to Broadcom in Q4 2023, an estimated $13.4M increase.
  • Profund Advisors's biggest Q4 2023 reduction was eBay, cutting an estimated $1.3M.
  • Profund Advisors fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $4.04M.
  • Profund Advisors's ten largest holdings make up 31% of its $2.33B portfolio in Q4 2023.
  • Profund Advisors opened 202 new positions and closed 43 in Q4 2023.
  • Profund Advisors's portfolio value rose 29% quarter-over-quarter to $2.33B.

Based on Profund Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.